Self‐Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine Development
IUBMB Life · 2026
DOI: 10.1002/iub.70097 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IUBMB Life, 2026. Verfasst von Chou-Yi Hsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan, Taiwan. Hauptthemen laut MEDLINE: Nanovaccines, Influenza Vaccines, Influenza, Human, Vaccine Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia.
Abstract (Originalsprache)
Influenza viruses present an ongoing global health risk because they are always changing, which in turn results in the ineffectiveness of current strain‐specific vaccines and leaves the world vulnerable to potential pandemics. The need for a universal influenza vaccine, designed to develop lasting broadly protective immunity against volatile influenza virus strains has led to advances in immunogen design. Nanotechnology, specifically self‐assembled nanovaccines, offers a truly revolutionary “bottom‐up” strategy to address this issue. Nanovaccines that spontaneously self‐assemble into easily discernable pathogen‐like nanoparticles, including protein cages (e.g., ferritin) and virus‐like particles, provide densely displayed conserved influenza epitopes—such as hemagglutinin (HA) stalk, neuraminidase (NA), and M2 ectodomain (M2e)—in a multivalent array, greatly enhancing B‐cell activation, initiated by extensive receptor crosslinking, and generating immune responses to a magnitude and breadth that is unattainable with soluble antigens. Moreover, self‐assembled nanovaccines, often in adjuvant‐free or self‐adjuvanting formulations, not only induce durable and broad cross‐protective humoral and cellular immunity but also offer protection from numerous heterosubtypic viral challenges. While significant hurdles remain in scaling the process to a manufacturing level and subsequently translating it into the clinic, self‐assembling nanovaccines represent a paradigm shift in influenza prevention, providing a rational and promising pathway toward the development of a universal vaccine and a rapid response platform for future pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
- Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia.
- Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Faculty of Nursing, Gokul Global University, Siddhpur, India.
- Department of Pharmacy Practice, College of Pharmacy, Dubai Medical University, Dubai, UAE.
- Department of Otolaryngology, College of Medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
ORCID-Profile: Chou-Yi Hsu, Ahmed Hjazi, Haider W Alsarhan
Förderung
- Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia
Zitieren
APA
Hsu, C. Y., Abdelrahim, I. M., Hjazi, A., Choubisa, H., Baig, M. R., Alsarhan, H. W., Arora, V., Basunduwah, T. S., Samantsinghar, P., & Singh, G. (2026). Self‐Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine Development. IUBMB Life. https://doi.org/10.1002/iub.70097
Vancouver
Hsu CY, Abdelrahim IM, Hjazi A, Choubisa H, Baig MR, Alsarhan HW, et al. Self‐Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine Development. IUBMB Life. 2026. doi:10.1002/iub.70097
BibTeX
@article{Hsu2026,
author = {Hsu, Chou-Yi and Abdelrahim, Ihab M and Hjazi, Ahmed and Choubisa, Hansraj and Baig, Mirza R and Alsarhan, Haider W and Arora, Vimal and Basunduwah, Tina Saeed and Samantsinghar, Pusparaj and Singh, Gunjan},
title = {Self‐Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine Development},
journal = {IUBMB Life},
year = {2026},
doi = {10.1002/iub.70097}
}
EUVIMED